EBONI:一种自动量化PSMA PET/CT中骨转移负荷的工具
研究介绍并验证了开源软件工具EBONI,用于在PSMA PET/CT中自动量化骨转移负荷(病灶数量、平均与最大病灶SUV、z评分、受累骨体积百分比),对38例不同骨受累程度的PSMA PET/CT扫描与专家视觉判读进行比较,显示自动与视觉确定的骨病灶数量高度相关,SUV阈值2.5为最佳,分析稳健、快速(每例扫描<3分钟)且100%可重复。
要点
- EBONI自动量化骨病灶数量与视觉判读高度相关(SUVmax r²=0.97;SUVmean r²=0.88;病灶计数 r²=0.97)。
- Hounsfield单位阈值对结果无显著影响,SUV阈值2.5被证明为自动病灶量化的最佳阈值。
- 假阳性组织误分类的系统误差低,主要发生在唾液腺和泪腺周围,易于校正;无假阴性判读。
核心结论
- EBONI分析稳健、快速(每例扫描<3分钟)且100%可重复,可实现转移性前列腺癌骨转移的判读者无关量化。
- EBONI提供的病灶量化与视觉评估等效,并提供补充信息,可作为PSMA PET/CT视觉分析的附加工具,具有缩短周转时间的潜力。
研究设计与样本
- 研究介绍开源软件工具EBONI(Evaluation of Bone Involvement),用于自动量化PSMA PET/CT中的骨转移负荷,确定病灶数量、平均与最大病灶SUV、z评分及受累骨体积百分比。
- 为验证EBONI,将38例不同骨受累程度的PSMA PET/CT扫描的自动量化结果与视觉专家判读进行比较,并分析SUV阈值和Hounsfield单位阈值的影响。
主要发现
- 自动与视觉确定的骨病灶数量高度相关:SUVmax r²=0.97,SUVmean r²=0.88,病灶计数 r²=0.97。
- Hounsfield单位阈值无显著影响,SUV阈值2.5被证明为自动病灶量化的最佳阈值。
- 假阳性组织误分类的系统误差低,主要发生在唾液腺和泪腺周围,易于校正;无假阴性判读。
关键数值与推荐
- 自动与视觉骨病灶数量相关性:SUVmax r²=0.97,SUVmean r²=0.88,病灶计数 r²=0.97。
- SUV阈值2.5被证明为自动病灶量化的最佳阈值;Hounsfield单位阈值无显著影响。
临床怎么用
- EBONI可容易地作为PSMA PET/CT扫描视觉分析的附加工具实施,并提供与视觉评估等效的病灶量化及补充信息。
- EBONI分析快速(每例扫描<3分钟)且100%可重复,具有缩短周转时间的潜力。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) PET/CT has a high diagnostic accuracy for lesion detection in metastatic prostate cancer, including bone metastases. Novel therapeutic approaches require valid biomarkers for standardized disease staging and for evaluation of progression and therapy response. Here, we introduce EBONI (Evaluation of Bone Involvement), a software tool to automatically quantify the bone metastasis load in PSMA PET/CT. Lesion quantity, mean and maximum lesional SUV, z score, and percentage of affected bone volume are determined. EBONI is open source and freely available. Methods: To validate EBONI, the results of automated quantification of 38 PSMA PET/CT scans with different levels of bone involvement were compared with visual expert reading. The influence of SUV threshold and Hounsfield unit thresholds was analyzed. Results: A high correlation between bone lesion quantity as determined visually and automatically was found (SUVmax, r2 = 0.97; SUVmean, r2 = 0.88; lesion count, r2 = 0.97). The Hounsfield unit threshold had no significant influence, whereas an SUV threshold of 2.5 proved optimal for automated lesion quantification. The systematic error of false-positive tissue misclassification was low, occurred mainly around the salivary and lacrimal glands, and could easily be corrected. There were no false-negative ratings. Conclusion: EBONI analysis is robust, quick (<3 min per scan), and 100% reproducible. It allows rater-independent quantification of bone metastasis in metastatic prostate cancer. It provides lesion quantification equivalent to that of visual assessment, as well as providing complementary information. It can be easily implemented as an add-on to visual analysis of PSMA PET/CT scans and has the potential to reduce turnaround time.
引用
- Hammes J, Täger P, Drzezga A, et al. EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT. J Nucl Med. 2017. PMID: 29242401. doi:10.2967/jnumed.117.203265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。